GLP1R and obstructive sleep apnea syndrome: IVW analysis revealed a significant association between genetically proxied GLP‐1R agonist exposure and decreased risk of OSA (OR = 0.83; 95% CI: 0.76 to 0.91; p = 6.15 × 10−5) (Figures 2 and 3).